๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A reproductive screening test of goldenseal

โœ Scribed by Mei Yao; Helen E. Ritchie; Patricia D. Brown-Woodman


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
92 KB
Volume
74
Category
Article
ISSN
1542-9733

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background:

Goldenseal (hydrastis canadensis l) is a multi-purpose herb (hobbs, 1990: pharm hist 32:79-82) widely used for its antibiotic properties. it is traditionally contraindicated in pregnancy based on in vivo data but this contraindication has not been confirmed by conventional studies that have been peer reviewed.

Methods:

Female rats were dosed by gavage using 65 times the human dose of goldenseal daily on either gestation days (gd) 1-8 or gd 8-15. controls received an equivalent dose of ethanol. on gd 20, fetuses were weighed and examined for signs of external, internal, or skeletal malformations. rat fetuses were also explanted on gd 10.5 and cultured with decreasing concentrations of goldenseal for 26 hr. embryos were examined for growth retardation and malformations.

Results:

There was no increase in pre- or post-implantation losses. there was no increase in fetal body weight in fetuses exposed to goldenseal. there was no difference in incidence of external or internal malformations. goldenseal induced toxicity when gd10.5 embryos were cultured for 26 hr in rat serum to which extract was added.

Conclusions:

It is likely that poor absorption of goldenseal from the small intestine could explain the discrepancy between the in vivo and in vitro results. it is unlikely that serum concentration from oral treatment could attain the loel achieved in vitro. the contrasting results highlight the continuing importance of in vivo work and the necessity of pharmacokinetic data when interpreting in vitro data. the data suggest that goldenseal, at the prescribed human dose, is unlikely to be absorbed to an extent to be unsafe to use in pregnancy despite the apparent cytotoxic effects in vitro. however, these results indicate that pharmacokinetic studies are required to confirm this conclusion.


๐Ÿ“œ SIMILAR VOLUMES


The test-retest reliability of the mccar
โœ Warren Umansky; Kathleen D. Paget; Linda R. Cohen ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 422 KB ๐Ÿ‘ 2 views

## A d a m County, Colorado Examined the test-retest reliability of the MST. Ss were 971 5-and 6-year-olds, who were tested early in the school year. Those "at risk" on the first test were retested 4 to 10 weeks later ( N = 276). Obtained reliability coefficients for the six subtests ranged from .

A short screening test for organic defic
โœ G. K. Butz; A. L. Hunsicker; D. E. Hurd ๐Ÿ“‚ Article ๐Ÿ“… 1959 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 520 KB
Assessing screening tests: extensions of
โœ Peter A. Lachenbruch; Cornelius J. Lynch ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB

We address the problem of comparing a new screening test to a currently available screening test in the absence of a gold standard. When both tests are given to each participant in a clinical trial, the usual analytical approach is to apply McNemar's test for equality of the off-diagonal probabiliti

Factor structure of the McCarthy screeni
โœ Booney Vance; Sonja Blixt; Donald L. Kitson ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 389 KB ๐Ÿ‘ 2 views